FTV· Information Technology› Scientific & Technical Instruments

Fortive Corporation

Stage 4 · Declining · week 3

As of Oct 22, 2026, Fortive is in Stage 4, the downtrend phase, now in week 3 (since Oct 6, 2026). It closed at $60.05, 6.2% below its 52-week high and above its 200-day average, which is rising.

Fortive Corporation designs, develops, manufactures, and markets products, software, and services in the United States, China, and internationally. More about the company

$60.05

+2.40% today

$18.1B · Large cap

Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Accelerating ⇈

Edge

—

Is FTV early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S4 14w

S2 37w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S2 9w → S3 6w → S4 7w → S1 2w → S2 13w → S3 8w → S4 14w → S1 10w → S2 3w → S3 2w → S2 10w → S3 2w → S4 10w → S1 4w → S4 13w → S1 7w → S2 37w → S3 5w → S4 2w current

Total tracked: 165 weeks across 19 stage runs.

FTV among Scientific & Technical Instruments9th of 32 by relative strength

All 32 →

Stocks in Scientific & Technical Instruments ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	KEYSKeysight Technologies Inc.	Stage 2 · wk 4	93	−11.8%
2	COHRCoherent Corp.	Stage 4 · wk 1	92	−30.9%
3	MLABMesa Laboratories, Inc.	Stage 2 · wk 10	90	−2.9%
4	VPGVishay Precision Group, Inc.	Stage 4 · wk 3	85	−24.5%
5	ITRNIturan Location and Control Ltd.	Stage 4 · wk 2	83	−2.9%
6	MKSIMKS Inc.	Stage 4 · wk 3	82	−25.4%
7	STSensata Technologies Holding plc	Stage 3 · wk 11	74	−2.0%
8	NOVTNovanta Inc.	Stage 3 · wk 10	71	−5.4%
9	FTVFortive Corporation	Stage 4 · wk 3	71	+6.7%

vs 52W High

-6.2%

$48.86 lo$64.01 hi

6.2% below 52W high, failed near resistance

In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.

Stage Maturity

Week 3

1w13w26w

Week 3, early Stage 4 decline

How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.

vs 200 DMA

2.9%

200 DMA: $58.35 · rising

In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.

Rel Volume

1.34x

vs 50-day avg

High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.

Trend Health

↗ ⇈

Short-term trend rising gently, and accelerating

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

+6.7%

-3.5%

-1.5%

YTD

+8.8%

+21.2%

Scan Membership

Breakout Watch

Latest: 2025-01-21

12 appearances in last 60 days. First seen: 2018-10-16.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S4

Wk 3 · Vol 1.34x

2026-10-21S4

Wk 3 · Vol 1.07x

2026-10-20S4

Wk 3 · Vol 1.00x

2026-10-19S4

Wk 2 · Vol 0.56x

2026-10-16S4

Wk 2 · Vol 0.61x

2026-10-15S4

Wk 2 · Vol 0.93x

2026-10-14S4

Wk 2 · Vol 0.98x

2026-10-13S4

Wk 2 · Vol 0.87x

2026-10-12S4

Wk 1 · Vol 0.47x

2026-10-09S4

Wk 1 · Vol 0.69x

2026-10-08S4

Wk 1 · Vol 0.92x

2026-10-07S4

Wk 1 · Vol 0.73x

Moving averages & range

50 DMA

$57.44

200 DMA

$58.35

52W High

$64.01

52W Low

$48.86

5D Low

$57.48

Resistance levels (recent highs)

20d High

$60.05

60d High

$61.73

120d High

$64.01

250d High

$64.01

Next resistance

+2.8%

to 60d High

P/E (TTM)

31.6

Forward 18.5

Earnings Growth (YoY)

+4.0%

Revenue +7.9%

ROE

+7.3%

Profit margin +12.4%

Dividend Yield

0.48%

P/B 3.0

Fortive: quick answers

What stage is Fortive in?

As of Oct 22, 2026, Fortive (FTV) is in Stage 4, the downtrend phase. It entered Stage 4 on Oct 6, 2026 and is in week 3. What the four stages mean

Is Fortive in an uptrend?

No. Fortive is in a Stage 4 downtrend. It trades 2.9% above its 200-day average, which is rising.

How far is Fortive from its 52-week high?

Fortive closed at $60.05 on Oct 22, 2026, 6.2% below its 52-week high of $64.01. Its 52-week low is $48.86.

How has Fortive performed over the past year?

As of Oct 22, 2026, Fortive is up 21.2% over the past year and up 8.8% so far in 2026.

Which sector and industry is Fortive in?

Fortive is in the Scientific & Technical Instruments industry, part of the Information Technology sector.

About this companyInformation Technology· Scientific & Technical Instruments

Fortive Corporation designs, develops, manufactures, and markets products, software, and services in the United States, China, and internationally. It operates through Intelligent Operating Solutions and Advanced Healthcare Solutions segments. The Intelligent Operating Solutions segment provides advanced instrumentation, software, and services, including maintenance, repair, measurement and condition monitoring, facility and asset lifecycle software applications, and connected worker safety and compliance solutions for manufacturing, process industries, healthcare, utilities and power, communications and electronics, and other industries. This segment markets its products and services under the ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, and SERVICECHANNEL brand names. The Advanced Healthcare Solutions segment provides critical workflow solutions comprising instrument sterilization, instrument tracking, biomedical test tools, radiation detection and safety monitoring, and end-to-end clinical productivity software and solutions under the ASP, CENSIS, FLUKE BIOMEDICAL, LANDAUER, and PROVATION brand names. Fortive Corporation was incorporated in 2015 and is headquartered in Everett, Washington.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.